OPT 1.27% 79.5¢ opthea limited

Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME, page-109

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,599 Posts.
    lightbulb Created with Sketch. 2662
    According to the DCF models I have seen from a couple of the analysts, FDA full approval value for wAMD and DME is $9 per share and $3 per share. Approx.
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
79.5¢
Change
0.010(1.27%)
Mkt cap ! $984.8M
Open High Low Value Volume
78.5¢ 80.5¢ 78.5¢ $131.2K 165.2K

Buyers (Bids)

No. Vol. Price($)
12 6246 79.5¢
 

Sellers (Offers)

Price($) Vol. No.
80.0¢ 13541 13
View Market Depth
Last trade - 11.15am 08/11/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.